General Information of the Compound
| Compound ID |
CP0552916
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
2-[(Z)-[(2E,5R,8R,9R,10R,12R,13R,14R,17S)-12-hydroxy-2-[(4-hydroxyphenyl)methylidene]-4,4,8,10,14-pentamethyl-17-[(2R)-2,6,6-trimethyloxan-2-yl]-5,6,7,9,11,12,13,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-ylidene]amino]guanidine
Show/Hide
|
||||||||||||||||||
| Formula |
C38H58N4O3
|
||||||||||||||||||
| Molecular Weight |
618.907
|
||||||||||||||||||
| Canonical SMILES |
C[C@@]12CC[C@@H]([C@H]1[C@H](O)C[C@@H]1[C@@]3(C)C\C(=C/c4ccc(O)cc4)\C(=N/NC(N)=N)\C(C)(C)[C@@H]3CC[C@@]21C)[C@@]1(C)CCCC(C)(C)O1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C38H58N4O3/c1-33(2)16-9-17-38(8,45-33)26-14-18-37(7)30(26)27(44)21-29-35(5)22-24(20-23-10-12-25(43)13-11-23)31(41-42-32(39)40)34(3,4)28(35)15-19-36(29,37)6/h10-13,20,26-30,43-44H,9,14-19,21-22H2,1-8H3,(H4,39,40,42)/b24-20+,41-31+/t26-,27+,28-,29+,30-,35-,36+,37+,38+/m0/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
ZPODEMQLIWTYQD-LYGYVDOWSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound